MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-12-0001533
Corona Pharmaceuticals Private Limited.
Corona Pharmaceuticals Private Limited. - healthcare in Kashipur, Uttarakhand, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.01 Cr
▲ 5% YoY
Net profit · FY 2025
₹2.14 Lakh
Net margin 0.4%
EBITDA · FY 2025
₹38.58 Lakh
EBITDA margin 6.4%
Authorised capital
₹1.3 Cr
Registered with MCA
Paid-up capital
₹76.74 Lakh
Issued & subscribed
Open charges
₹2.14 Cr
Satisfied ₹95 Lakh
Company age
18 yrs
Est. 2008
Employees · EPFO
53
Provident fund records
About Corona Pharmaceuticals Private Limited.
Data last updated:
Corona Pharmaceuticals Private Limited. is a private limited company based in Kashipur, Uttarakhand, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 24 September 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U85100UR2008PTC032700. Its GSTIN is 05AADCC5679H1ZI (Uttarakhand).
The company has an authorised share capital of ₹1.3 Cr and a paid-up capital of ₹76.74 Lakh. It is led by directors including Satanshu Mathur and Vivek Khandelwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 7th Milestone Jaspur Roas Kunda Crossing, Kashipur, Uttarakhand, India – 244713.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.01 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹2.14 Lakh (net margin 0.4%) and EBITDA of ₹38.58 Lakh (EBITDA margin 6.4%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 2% over five years.
The company has about 53 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2.14 Cr and satisfied charges of ₹95 Lakh on record. Court records list 7 cases involving the company, including 3 filed by the company and 4 filed against it; 3 cases are pending.
Corona Pharmaceuticals Private Limited. is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-12-0001533). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U85100UR2008PTC032700
Registration Number 032700
Incorporation Date 24 September 2008
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-12-0001533
Recognitions & Rankings of Corona Pharmaceuticals Private Limited
Contact details
Corona Pharmaceuticals Private Limited.'s registered office is in Kashipur, Uttarakhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address7th Milestone Jaspur Roas Kunda Crossing, Kashipur, Uttarakhand, India – 244713
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Corona Pharmaceuticals Private Limited., buy the company report.
Comprehensive company report
Corona Pharmaceuticals Private Limited. - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Corona Pharmaceuticals Private Limited is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Corona Pharmaceuticals Private Limited., buy the company report.
Financials of Corona Pharmaceuticals Private Limited.
FY 2024 filings availableCorona Pharmaceuticals Private Limited. reported revenue of ₹6.01 Cr (up 5% YoY) for FY 2025.
Revenue · FY 2025
₹6.01 Cr ▲ 5%
Net profit · FY 2025
₹2.14 Lakh margin 0.4%
EBITDA · FY 2025
₹38.58 Lakh margin 6.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 4%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 21%
5 years · compounded
▲ 5%
Revenue rose 5% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹38.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.4% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Corona Pharmaceuticals Private Limited., buy the company report.
Board of directors of Corona Pharmaceuticals Private Limited.
Corona Pharmaceuticals Private Limited has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satanshu Mathur Also directs: Devbhoomi Healthcare LLP, Twenty Twenty Eye Care Private Limited | Director | 10 Dec 2008 | 17 Years 10 Months | Current |
| Babita Dixit | Additional Director | 01 Apr 2021 | 5 Years 6 Months | Current |
| Vivek Khandelwal Also directs: Khandelwal Hospital and Urology Centre Private Limited | Director | 31 Jul 2023 | 3 Years 3 Months | Current |
Peer comparison
Corona Pharmaceuticals Private Limited. is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nyx Pharmaceuticals Private Limited | ₹6.02 Cr (FY 2024) | 32.0% | Chandigarh, India | |||
| Corona Pharmaceuticals Private Limited.this company | ₹6.01 Cr (FY 2025) | ₹2.14 Lakh | 0.4% | 5.0% | 53 | Kashipur, Uttarakhand, India |
| Aquinnova Pharmaceuticals Private Limited | ₹5.98 Cr (FY 2025) | 7.0% | Indore, Madhya Pradesh, India | |||
| Eden Health Care Private Limited | ₹5.96 Cr (FY 2025) | 11.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Corona Pharmaceuticals Private Limited., buy the company report.
Auditor
Corona Pharmaceuticals Private Limited. is audited by N ARORA & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N ARORA & ASSOCIATES | FY 2024 | 500581 |
Shareholding
The shareholding of Corona Pharmaceuticals Private Limited. is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Corona Pharmaceuticals Private Limited., buy the company report.
Charges & borrowings
Open charges
₹2.14 Cr
Satisfied charges
₹95 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Aug 2023 | 100770694 | Others | ₹14 Lakh | Open | |
| 30 Jun 2022 | 100593888 | Others | ₹2 Cr | Open | |
| 06 Jul 2018 | 100190772 | Others | ₹95 Lakh | Satisfied |
To see the full charge records of Corona Pharmaceuticals Private Limited., buy the company report.
Total charge records: 3 View all charges
Legal cases
Corona Pharmaceuticals Private Limited. has 7 court cases on record: 3 filed by Corona Pharmaceuticals Private Limited, 4 filed against it. 3 cases are pending and 4 are disposed.
Total cases
7
Filed by the company
3
Filed against the company
4
Pending
3
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 3 | 3 |
| High courts | 2 | 1 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Udham Singh Nagar, Uttarakhand | Criminal case | Filed by the company against God Bless Pharma Pvt Ltd | Pending |
| High Court, GUJARAT | Court case (AO) | Filed against the company by Corona Remedies Private Limited and 2 others | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed against the company by Corona Remedies Private Limited and 1 other | Disposed |
| District court, Muzaffarpur, Bihar | Court case (Cr. Case Complaint (O)) | Filed against the company by an individual | Pending |
| District court, Udham Singh Nagar, Uttarakhand | Criminal case | Filed by the company against an individual | Pending |
To see the full case history of Corona Pharmaceuticals Private Limited., buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Corona Pharmaceuticals Private Limited.; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Corona Pharmaceuticals Private Limited. has a workforce of 53 employees on its EPFO records as of Mar 29, 2025, across 1 active EPFO establishment.
Employee count
53
Active EPFO establishments
1
Employee growth
10.42%
GST
Corona Pharmaceuticals Private Limited has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AADCC5679H1ZI | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Corona Pharmaceuticals Private Limited., buy the company report.
Recent activity
Corona Pharmaceuticals Private Limited. has 8 board changes on record since 2008: 3 appointments and 5 cessations. The latest: Vivek Khandelwal was appointed as Director on 31 Jul 2023.
AGM
Corona Pharmaceuticals Private Limited. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Corona Pharmaceuticals Private Limited. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand.
Charges
A charge with Others amounted to Rs. 0.14 Cr with Charge ID 100770694 was registered on 14 Aug 2023.
Appointed
Vivek Khandelwal was appointed as Director.
Charges
A charge registered on 06 Jul 2018 via Charge ID 100190772 with Others was fully satisfied on 15 Jul 2022.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100593888 was registered on 30 Jun 2022.
Ceased
Kush Agarwal ceased to be Additional Director.
Appointed
Babita Dixit was appointed as Additional Director.
Ceased
Babita Dixit ceased to be Director.
Ceased
Sudhanshu Mathur ceased to be Director.
Charges
A charge with Others amounted to Rs. 0.95 Cr with Charge ID 100190772 was registered on 06 Jul 2018.
Ceased
Pramod Kumar ceased to be Director.
3 earlier events are in the company report.
Frequently asked questions
Corona Pharmaceuticals Private Limited is an active private limited company based in Kashipur, Uttarakhand, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 24 September 2008 (18+ years old) and is registered under CIN U85100UR2008PTC032700.
Corona Pharmaceuticals Private Limited has 3 current directors:
- Satanshu Mathur - Director
- Babita Dixit - Additional Director
- Vivek Khandelwal - Director
The latest financial statements of Corona Pharmaceuticals Private Limited on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Corona Pharmaceuticals Private Limited is 05AADCC5679H1ZI, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Corona Pharmaceuticals Private Limited is U85100UR2008PTC032700. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Corona Pharmaceuticals Private Limited has 7 court cases on record: 3 filed by the company and 4 filed against it. 3 are pending. Most are in the district courts.
Corona Pharmaceuticals Private Limited was incorporated on 24 September 2008, making it 18+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Corona Pharmaceuticals Private Limited by revenue are Nyx Pharmaceuticals Private Limited, Aquinnova Pharmaceuticals Private Limited, Eden Health Care Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Vivek Khandelwal was appointed as Director on 31 Jul 2023. Kush Agarwal ceased to be Additional Director on 09 Apr 2021. Babita Dixit was appointed as Additional Director on 01 Apr 2021. Corona Pharmaceuticals Private Limited has 8 board changes on record in total.
Yes, Corona Pharmaceuticals Private Limited is registered as a small enterprise under Udyam registration (number: UDYAM-UK-12-0001533).
The registered office of Corona Pharmaceuticals Private Limited is at 7th Milestone Jaspur Roas Kunda Crossing, Kashipur, Uttarakhand, India – 244713.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages